We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DCOM:NASDAQDime Community Bancshares, Inc. Analysis

Data as of 2026-06-08 - not real-time

$38.04

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Dime Commercial Bancshares (DCOM) is trading at $38.04, comfortably above its 20‑day SMA of $36.89 and 50‑day SMA of $36.20, indicating short‑term momentum. The stock sits just below the 52‑week high of $38.63, with a technical support level near $35.14 and a bullish MACD histogram (+0.05) reinforcing upward pressure. Momentum indicators remain healthy, with an RSI of 60 and a trend direction flagged as bullish, while volume has been tapering, suggesting a potential consolidation phase. On the fundamentals side, revenue surged 19% year‑over‑year to $123.6 million, yet Q1 non‑GAAP EPS of $0.74 missed consensus, creating a modest earnings drag. Valuation metrics show a trailing P/E of 14.3 versus the industry average of 16.9, and a forward P/E of 8.7, positioning DCOM as a relative cheap play in the regional‑bank space. The dividend yield of 2.65% with a payout ratio of 38% and a solid cash pile of $2.13 billion further bolsters the appeal.
The DCF model projects a fair value of $105, implying an upside of roughly 13% over the current price, though the extreme greed sentiment (Fear‑Greed Index 88) hints at heightened market enthusiasm. Volatility over the past 30 days sits at 23.5% and beta is near 1.0, indicating market‑aligned risk without excessive leverage (debt‑to‑equity effectively zero). Recent strategic moves—including the launch of an equipment‑and‑franchise finance group and the acquisition of former Signature Bank space in Williamsburg—signal a proactive growth agenda. Despite the earnings miss, the strong operating margin of 44% and a ROE of 8.5% suggest resilient profitability. The combination of modest valuation, attractive dividend, and expanding loan portfolio supports a view that the stock is currently undervalued yet positioned for steady upside. Investors should monitor volume trends and upcoming earnings for confirmation, but the overall picture remains cautiously optimistic.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators near resistance
  • Q1 earnings miss relative to consensus
  • Decreasing volume suggesting short‑term consolidation

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 19% revenue growth and strong operating margins
  • Attractive valuation versus industry peers
  • Sustainable dividend yield of 2.65%

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF implied upside and long‑term growth initiatives
  • Robust cash position and low leverage
  • Consistent dividend policy supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth18.10%
Profit Margin29.00%
P/E Ratio14.3
ROE8.51%
ROA0.85%
P/B Ratio1.2
Op. Cash Flow$169.1M
Industry P/E16.9

Technical Analysis

TrendBullish
RSI60.4
Support$35.14
Resistance$38.63
MA 20$36.89
MA 50$36.20
MA 200$32.09
MACDBullish
VolumeDecreasing
Fear & Greed Index88.16

Valuation

Fair Value$105.28
Target Price$43.00
Upside/Downside13.04%
GradeUndervalued
TypeBlend
Dividend Yield2.65%

Risk Assessment

Beta1.00
Volatility23.51%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.